Overview

Efficacy Study of a Low Volume of Water Intake and Mosapride for Endoscopy in Patients With Subtotal Gastrectomy

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
0
Participant gender:
All
Summary
A low volume of water intake and mosapride will effectively reduce food residue in remnant stomach for patients who had undergone subtotal gastrectomy due to gastric cancer.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Inje University
Treatments:
Mosapride
Criteria
Inclusion Criteria:

- Outpatients who had subtotal gastrectomy for gastric cancer

Exclusion Criteria:

- Pregnancy

- Lactation

- History of anastomotic stricture

- Recurrent advanced gastric cancer

- Poor general condition( > 2 ECOG)

- Other disseminated malignancy

- Significant renal failure or congestive heart failure (CHF)

- Liver failure